Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its ...
On Friday, the Food and Drug Administration announced a new pilot prioritization program for the review of abbreviated new drug applications that aims to spur and reward investment in U.S. drug ...
This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...
WILMINGTON, Del., Dec. 02, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration ...
The US Food and Drug Administration (FDA) has released new draft guidance offering recommendations for applicants to prove sameness in active ingredients of abbreviated new drug application (ANDA) ...
Orbicular and Gland Pharma announce first ANDA approval with CGT for generic infuvite parenteral nutrition injectable in partnership with Apotex: Our Bureau, Mumbai Thursday, Apri ...
Onesource said Orbicular Pharma with its US-based front-end partner have secured the US Food and Drug administration (USFDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results